SCHEMBL23905370

SCHEMBL23905370

CC(=O)Oc1cc(C)cc2cc(F)cnc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.37
CYP4F2 P78329 2/20 0.35
CYP4A11 Q02928 2/20 0.35
AGBL2 Q5U5Z8 1/20 0.35
ALDH1A1 P00352 3/20 0.33
LMNA P02545 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KMT2A Q03164 2/20 0.33
MAOB P27338 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
MEN1 O00255 1/20 0.33
S1PR2 O95136 1/20 0.33
TP53 P04637 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23905294 0.81 PSMD14 (0.40) ALDH1A1LMNASMN1; SMN2KMT2ANPC1
SCHEMBL27887074 0.75 PSMD14 (0.51) ALDH1A1LMNASMN1; SMN2KMT2AMEN1
SCHEMBL23905323 0.73 SYK (0.36) CCR1CCR5CCR8
SCHEMBL7466188 0.72 PARP1 (0.56) ALDH1A1LMNAKMT2AMAOBGAA
SCHEMBL12211032 0.70 CYP4F2 (0.38) CYP4F2CYP4A11AGBL2ALDH1A1RAB9A
SCHEMBL27896418 0.68 AGBL2 (0.47) CYP4F2CYP4A11AGBL2ALDH1A1LMNA
SCHEMBL23195634 0.68 CA12 (0.47) LMNARAB9AMAPK1HTT
SCHEMBL13021618 0.67 ELANE (0.50) ELANEALDH1A1LMNASMN1; SMN2NPC1
SCHEMBL23905372 0.67 KDM4E (0.45) ALDH1A1LMNASMN1; SMN2KMT2AMEN1
SCHEMBL4940831 0.66 SSTR4 (0.40) CYP4F2CYP4A11AGBL2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed